Analyst Ratings for Orchard Therapeutics (ORTX)
ORTX Rating Summary
ORTX Price Target Summary
- Highest: $34.00 (Oppenheimer)
- Lowest: $16.00 (Stifel)
- Average: $25.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.00 (+49.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
Avg. $ Target:
$25.00 (+49.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2023 | Stifel | Dae Gon Ha | Downgrade | Hold (Buy) |
16.00 (22.00) |
8.14 (16.70) |
105.16% | Details |
| 7/18/2022 | Oppenheimer » Updated 6/13/2023 |
Hartaj Singh | New Coverage | Outperform (N/A) |
34.00 (37.00) |
0.60 (16.70) |
2683.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
